5-Amino-1MQ is a small-molecule, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT) designed exclusively for in vitro and animal model investigation. By selectively restricting NNMT activity, this research compound prevents the irreversible methylation of nicotinamide, conserving cellular NAD+ pools and altering methyl donor availability. Investigators utilize 5-Amino-1MQ to evaluate metabolic flux, mitochondrial biogenesis, and adipocyte dynamics in controlled laboratory environments.
5-Amino-1MQ is a small-molecule, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT) designed exclusively for in vitro and animal model investigation. By selectively restricting NNMT activity, this research compound prevents the irreversible methylation of nicotinamide, conserving cellular NAD+ pools and altering methyl donor availability. Investigators utilize 5-Amino-1MQ to evaluate metabolic flux, mitochondrial biogenesis, and adipocyte dynamics in controlled laboratory environments.
The 5-amino-1mq research chemical represents a distinct class of selective small-molecule inhibitors targeted at metabolic enzymes. Developed primarily to modulate cellular energy pathways, 5-Amino-1MQ (5-amino-1-methylquinolinium) functions by binding to and suppressing the activity of nicotinamide N-methyltransferase (NNMT). NNMT is a cytosolic enzyme predominantly expressed in metabolic tissues, including white adipose tissue, the liver, and skeletal muscle.
Unlike biological peptides that act as extracellular ligand agonists for G-protein coupled receptors, 5-Amino-1MQ is a membrane-permeable quinolinium derivative. Its low molecular weight and structural charge distribution allow it to enter targeted cellular environments directly. In high-throughput screenings and structural biology assays, the molecule has demonstrated high affinity for the NNMT substrate-binding pocket, blocking the methyl transfer reaction without broadly inhibiting other methyltransferases. Laboratory investigators source high-purity 5-Amino-1MQ research compounds to interrogate intracellular metabolic cascades without the confounding variables of non-specific kinase or transferase suppression.
To understand the mechanism of the 5-amino-1mq research chemical, one must examine the role of NNMT in cellular biochemistry. NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing S-adenosylhomocysteine (SAH) and 1-methylnicotinamide (1-MNA). Because 1-MNA is rapidly excreted by the cell, this reaction acts as a primary sink for both methyl donors and nicotinamide availability.
When NNMT activity is elevated—such as in obese mouse models or high-fat diet cell assays—nicotinamide is rapidly depleted. This depletion starves the NAD+ salvage pathway, leading to decreased intracellular nicotinamide adenine dinucleotide (NAD+) levels. Reduced NAD+ availability impairs the activity of NAD+-dependent enzymes, including sirtuins (SIRT1–SIRT7) and poly(ADP-ribose) polymerases (PARPs), which are critical for oxidative phosphorylation, DNA repair, and epigenetic regulation.
By applying 5-Amino-1MQ in vitro, researchers effectively halt the enzymatic methylation of NAM. Preclinical studies suggest that suppressing NNMT causes a rapid accumulation of intracellular nicotinamide, which is subsequently recycled into NAD+ via the enzyme nicotinamide phosphoribosyltransferase (NAMPT). Consequently, cells treated with this compound show elevated NAD+ concentrations and increased SIRT1 signaling, supporting enhanced mitochondrial respiration and oxidative capacity.
Research evaluating the 5-amino-1mq research chemical has largely focused on metabolic regulation in rodent models of diet-induced obesity and in primary adipocyte cultures. In vitro data indicate that inhibiting NNMT in mature 3T3-L1 adipocytes leads to a structural reorganization of lipid droplets, increased basal oxygen consumption rate (OCR), and elevated expression of mitochondrial markers such as PGC-1α and UCP1.
In vivo animal studies using diet-induced obese (DIO) mice have demonstrated that systemically administering NNMT inhibitors results in reduced body mass expansion without alterations in caloric intake. Researchers observed that the treated animal cohorts exhibited improved glucose tolerance, enhanced insulin sensitivity in skeletal muscle, and reduced lipogenesis in white adipose tissue. These findings strongly suggest that NNMT plays a master regulatory role in adipose tissue energy expenditure, rendering small-molecule inhibitors like 5-Amino-1MQ indispensable tools for studying metabolic disease modeling and energy homeostasis.
For laboratories conducting comparative assays across metabolic modulation pathways, reviewing our full catalog of all-peptides and small molecules provides access to complementary targets operating via receptor-mediated or enzymatic mechanisms.
Beyond its downstream effects on NAD+ salvage, NNMT exerts a profound influence on cellular epigenetics. SAM serves as the primary methyl donor for DNA methyltransferases (DNMTs) and histone methyltransferases (HMTs). Because NNMT is a high-capacity consumer of SAM in metabolic tissues, high NNMT expression drains the intracellular SAM pool and alters the SAM-to-SAH ratio.
Preclinical evidence demonstrates that inhibiting NNMT with the 5-amino-1mq research chemical restores intracellular SAM availability. This elevation in SAM availability alters histone methylation patterns—specifically H3K4 and H3K27 methylation—at key genetic loci regulating adipogenesis and cell fate determination. Laboratory researchers frequently employ 5-Amino-1MQ to study the cross-talk between metabolic flux, methyl-donor availability, and epigenetic transcription control in stem cell differentiation and metabolic profiling.
When designing preclinical trials focused on metabolic rate, lipid oxidation, and mitochondrial capacity, investigators often compare 5-Amino-1MQ against other research compounds operating on distinct molecular pathways. While 5-Amino-1MQ targets an intracellular enzyme directly, peptide-based research compounds typically target membrane-bound receptor complexes.
For instance, mitochondrial-derived peptides like MOTS-c activate the AMPK pathway directly to enhance fatty acid oxidation and metabolic flexibility. In contrast, lipolytic fragments such as AOD-9604 stimulate lipolysis via localized beta-adrenergic pathway modulation without impacting cellular NAD+ pools. Furthermore, multi-receptor agonists like Retatrutide operate through GLP-1, GIP, and glucagon receptor activation to modify systemic metabolic signaling. The table below summarizes these physiological distinctions for laboratory benchmarking:
1. **5-Amino-1MQ**: Primary target is intracellular NNMT enzyme inhibition. Primary cellular effect is NAD+ conservation, SAM/SAH ratio modulation, and elevated SIRT1 activity. Studied primarily in adipocyte metabolism and tissue-specific oxidative capacity.
2. **MOTS-c**: Primary target is mitochondrial ribosome encoding and AMPK activation. Primary cellular effect is translocation to the nucleus under metabolic stress to regulate folate and purine synthesis. Studied in systemic metabolic flexibility and exercise-mimetic pathways.
3. **AOD-9604**: Primary target is fat-cell human growth hormone receptor domains. Primary cellular effect is lipolytic signal transduction without affecting systemic glucose transport or intracellular methyl donor pools.
4. **Retatrutide**: Primary target is triple GIP/GLP-1/Glucagon receptor agonism. Primary cellular effect is central and peripheral gut-brain axis modulation, appetite suppression modeling, and insulinotropic signaling.
Proper handling and solution preparation are vital to maintaining the chemical integrity of the 5-amino-1mq research chemical in experimental settings. As a charged quinolinium salt, 5-Amino-1MQ exhibits distinct solubility characteristics compared to hydrophobic small molecules or uncharged peptides.
For standard cell culture assays, 5-Amino-1MQ is soluble in dimethyl sulfoxide (DMSO) at concentrations exceeding 20 mg/mL, and in sterile double-distilled water or phosphate-buffered saline (PBS) up to specific concentration limits depending on ionic strength. Stock solutions prepared in DMSO should be aliquoted under sterile conditions to avoid freeze-thaw cycles and stored at -80°C. Working solutions diluted into aqueous culture media should be prepared immediately prior to administration in vitro to prevent hydrolysis or chemical degradation over extended incubation windows.
To explore complementary protocol designs or review analytical standards for related compounds, visit the centralized PX1 research library hub.
The scientific validity of preclinical assays depends entirely on compound purity, structural identity, and freedom from toxic manufacturing contaminants. When evaluating suppliers for 5-amino-1mq research chemicals, laboratory purchasing managers must require comprehensive, lot-specific analytical documentation.
PX1 Research enforces rigorous quality assurance standards for every production batch, including:
• **Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC)**: Confirms compound purity levels exceed 98.0%, ensuring peak integration is free from synthesis side-products or unreacted precursor residues.
• **Mass Spectrometry (MS)**: Electrospray ionization mass spectrometry (ESI-MS) confirms exact molecular weight and structural identity against calculated molecular formulas.
• **Bacterial Endotoxin Testing (LAL Assay)**: Quantitative chromogenic LAL testing verifies endotoxin levels remain below strict threshold limits (<0.01 EU/mg), preventing non-specific inflammatory responses in sensitive cell lines or rodent models.
• **Lot Traceability & Storage**: Every vial features dedicated lot numbers linked directly to published, third-party Certificates of Analysis (COAs) generated by accredited ISO 17025 laboratories.
Procuring research compounds for institutional, university, or private laboratory facilities requires selecting partners operating within standardized quality management frameworks. Substandard or unverified chemicals introduce significant experimental noise, leading to irreproducible cellular assays or unexpected animal toxicity.
PX1 Research produces all compounds within state-of-the-art, GMP-compliant facilities located exclusively in the USA. Shipments originate directly from domestic distribution centers in California and Arizona, ensuring same-day dispatch for orders finalized before cut-off times (Monday through Friday). This domestic cold-chain and rapid logistics setup minimizes thermal degradation risk during transit. For institutional purchasing departments requiring bulk supply, high-volume batch testing, or customized contract manufacturing, explore our wholesale lab account options to establish dedicated supply lines.
What is the primary target of the 5-amino-1mq research chemical?
The primary molecular target of 5-Amino-1MQ is the enzyme nicotinamide N-methyltransferase (NNMT). It acts as a membrane-permeable, selective small-molecule inhibitor of this cytosolic enzyme.
How does 5-Amino-1MQ influence cellular NAD+ levels in preclinical models?
By inhibiting NNMT, 5-Amino-1MQ prevents the methylation and subsequent clearance of nicotinamide. This conserves nicotinamide, allowing the cellular salvage pathway via NAMPT to convert it back into NAD+, thereby elevating intracellular NAD+ pools.
Is 5-Amino-1MQ suitable for human consumption or therapeutic use?
No. 5-Amino-1MQ is strictly designated for laboratory research use only (RUO). It is not cleared, approved, or formulated for human consumption, clinical use, or therapeutic administration.
What solvents are recommended for reconstituting 5-Amino-1MQ for cell culture?
5-Amino-1MQ is typically dissolved in research-grade DMSO for high-concentration stock solutions. It can also be dissolved directly in sterile physiological saline or PBS depending on final target concentrations for in vitro assays.
How should lyophilized or powdered 5-Amino-1MQ be stored?
Lyophilized powder should be stored in a desiccated container at -20°C for long-term stability. Once reconstituted into liquid aliquots, store at -80°C and minimize repeat freeze-thaw cycles.
What analytical testing is performed on PX1 5-Amino-1MQ lots?
Every lot undergoes independent third-party analytical verification using RP-HPLC for chemical purity (≥98%), Electrospray Mass Spectrometry (ESI-MS) for structural identity, and LAL assays for endotoxin quantification.
How does 5-Amino-1MQ differ from peptide metabolic compounds like MOTS-c?
5-Amino-1MQ is a small-molecule direct enzyme inhibitor operating intracellularly on NNMT. MOTS-c is a mitochondrial-derived peptide that acts via broader intracellular signaling cascades and AMPK activation.
Where are PX1 Research compounds manufactured and dispatched from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from fulfillment centers located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.